4.18
-0.18(-4.13%)
Currency In USD
| Previous Close | 4.36 |
| Open | 4.37 |
| Day High | 4.64 |
| Day Low | 4.18 |
| 52-Week High | 4.99 |
| 52-Week Low | 1.8 |
| Volume | 68,132 |
| Average Volume | 67,640 |
| Market Cap | 49.39M |
| PE | -3.6 |
| EPS | -1.16 |
| Moving Average 50 Days | 3.64 |
| Moving Average 200 Days | 3.14 |
| Change | -0.18 |
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Newsfile
Apr 28, 2025 11:30 AM GMT
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent PaymentsAntev is developing Teverelix, A next generation GnRH Antagonist, as first in class market product for Acute Urinary Retention (AUR) and hi
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
Newsfile
Apr 21, 2025 11:30 AM GMT
The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90).The Company to Expand the Study into Additional Trial Sites in EuropePhiladelphia, Pennsylvania--(Newsfile Corp. - April 21, 2025) - Medicu
Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering
Newsfile
Mar 10, 2025 8:05 PM GMT
Philadelphia, Pennsylvania--(Newsfile Corp. - March 10, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced Tier II Regulation A offering of 1,490,000 units, on a "best-efforts" basis, at